Abstract:<h3 class="a-plus-plus">Abstract</h3> Primary and secondary lymphoid organs are heavily innervated by the autonomic nervous system. Norepinephrine, the primary neurotransmitter secreted by post-ganglionic sympathetic neurons, binds to and activates β-adrenergic receptors expressed on the surface of immune cells and regulates the functions of these cells. While it is known that both activated and memory CD8+ T-cells primarily express the β2-adrenergic receptor (β2-AR) and that signaling through this receptor can inhibit CD8+ T-cell effector function, the mechanism(s) underlying this suppression is not understood. Under normal activation conditions, T-cells increase glucose uptake and undergo metabolic reprogramming. In this study, we show that treatment of murine CD8+ T-cells with the pan β-AR agonist isoproterenol (ISO) was associated with a reduced expression of glucose transporter 1 following activation, as well as decreased glucose uptake and glycolysis compared to CD8+ T-cells activated in the absence of ISO. The effect of ISO was specifically dependent upon β2-AR, since it was not seen in adrb2−/− CD8+ T-cells and was blocked by the β-AR antagonist propranolol. In addition, we found that mitochondrial function in CD8+ T-cells was also impaired by β2-AR signaling. This study demonstrates that one mechanism by which β2-AR signaling can inhibit CD8+ T-cell activation is by suppressing the required metabolic reprogramming events which accompany activation of these immune cells and thus reveals a new mechanism by which adrenergic stress can suppress the effector activity of immune cells.

Adenosine Mediated Desensitization Of Camp Signaling Enhances T-Cell Responses

Detrimental Effects of Adenosine Signaling in Sickle Cell Disease

Adenosine Primes Resting Stage Dendritic Cells Before Their Activation.

Adenosine deamination sustains dendritic cell activation in inflammation.

Impact of Regulatory T Cells on Innate Immune Cells in a Pre-Sensitized Heart Transplant Model

The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway

Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function

Adenosine production: a common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression

Inactivation Of T-Cell Receptor-Mediated Integrin Activation Prolongs Allograft Survival In Amap-Deficient Mice

The inhibitory effect of adenosine on tumor adaptive immunity and intervention strategies

Targeting immunosuppressive adenosine in cancer

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

β-Adrenergic signaling blocks murine CD8+ T-cell metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress

Targeting adenosine for cancer immunotherapy

Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co‐Operation with T cells

High levels of adenosine deaminase on dendritic cells promote autoreactive T cell activation and diabetes in nonobese diabetic mice.

Correction: Levels of Adenosine Deaminase on Dendritic Cells Promote Autoreactive T Cell Activation and Diabetes in Nonobese Diabetic Mice

Cutting Edge: Elimination of an Endogenous Adjuvant Reduces the Activation of Cd8 T Lymphocytes to Transplanted Cells and in an Autoimmune Diabetes Model

Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity

Targeting Adenosine Receptor Signaling in Cancer Immunotherapy

Cutting Edge: Dexamethasone Potentiates the Responses of Both Regulatory T Cells and B-1 Cells to Antigen Immunization in the ApoE−/− Mouse Model of Atherosclerosis